Wird geladen...

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

OBJECTIVE: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pacchiarotti, Isabella, Bond, David J., Baldessarini, Ross J., Nolen, Willem A., Grunze, Heinz, Licht, Rasmus W., Post, Robert M., Berk, Michael, Goodwin, Guy M., Sachs, Gary S., Tondo, Leonardo, Findling, Robert L., Youngstrom, Eric A., Tohen, Mauricio, Undurraga, Juan, González-Pinto, Ana, Goldberg, Joseph F., Yildiz, Ayşegül, Altshuler, Lori L., Calabrese, Joseph R., Mitchell, Philip B., Thase, Michael E., Koukopoulos, Athanasios, Colom, Francesc, Frye, Mark A., Malhi, Gin S., Fountoulakis, Konstantinos N., Vázquez, Gustavo, Perlis, Roy H., Ketter, Terence A., Cassidy, Frederick, Akiskal, Hagop, Azorin, Jean-Michel, Valentí, Marc, Mazzei, Diego Hidalgo, Lafer, Beny, Kato, Tadafumi, Mazzarini, Lorenzo, Martínez-Aran, Anabel, Parker, Gordon, Souery, Daniel, Özerdem, Ayşegül, McElroy, Susan L., Girardi, Paolo, Bauer, Michael, Yatham, Lakshmi N., Zarate, Carlos A., Nierenberg, Andrew A., Birmaher, Boris, Kanba, Shigenobu, El-Mallakh, Rif S., Serretti, Alessandro, Rihmer, Zoltan, Young, Allan H., Kotzalidis, Georgios D., MacQueen, Glenda M., Bowden, Charles L., Ghaemi, S. Nassir, Lopez-Jaramillo, Carlos, Rybakowski, Janusz, Ha, Kyooseob, Perugi, Giulio, Kasper, Siegfried, Amsterdam, Jay D., Hirschfeld, Robert M., Kapczinski, Flávio, Vieta, Eduard
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091043/
https://ncbi.nlm.nih.gov/pubmed/24030475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2013.13020185
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!